WILLIAM MCCULLOCH
Pilots at Betts Ln, Raleigh, NC
License number
North Carolina A3934984
Issued Date
Jun 2016
Expiration Date
Jun 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
12109 Betts Ln, Raleigh, NC 27614
Personal information
See more information about WILLIAM MCCULLOCH at radaris.comName
Address
Phone
5800 Old Providence Rd APT 5, Charlotte, NC 28226
5800 Old Providence Rd APT 570, Charlotte, NC 28226
7562 Firethorn Dr, Fayetteville, NC 28311
168 G P Deal Rd, Boone, NC 28607
12413 Cilcain Ct, Raleigh, NC 27614
Professional information
See more information about WILLIAM MCCULLOCH at trustoria.com
Sap| Lean Six Sigma| Business Process|Sales &Amp; Operation Planning|Production Control |Distribution|Logistics|Supply Chain
Sap| Lean Six Sigma| Business Process|Sales &Amp; Operation Planning|Production Control |Distribution|Logistics|Supply Chain
Location:
Raleigh-Durham, North Carolina Area
Industry:
Computer Hardware
Work:
IBM
- RTP, NC Jan 2006 - Sep 2012
-
Advanced Application Development Analyst
IBM
- RTP, NC Mar 2001 - Dec 2005
-
Advisory Software Engineer
Tenneco
- Lake Forest, IL May 1996 - Dec 2000
-
SAP Project Manager - Distribution
Tenneco
- Paragould, AR Jun 1994 - Apr 1996
-
Distribution Center Shift Superintendent
Tenneco
- Cozad, NE Sep 1989 - May 1994
-
Shipping Supervisor / OEM Master Scheduler
Tenneco
- Monroe, MI Jun 1987 - Aug 1989
-
Aftermarket Master Scheduler
Magellan Aerospace UK Ltd
- Middletown, OH May 1986 - May 1987
-
Manager, Production Stores
Northrop Grumman Corporation
- Kansas City, MO Sep 1984 - Apr 1986
-
Material Control Specialist
Siemens-Allis
- Bellefontaine, OH Nov 1981 - Aug 1984
-
Production Planning, Scheduling, and Control
Education:
Bowling Green State University
Bachelor of Science in Business Administration, Production Operations Management/ Procurement and Materials Management
Bachelor of Science in Business Administration, Production Operations Management/ Procurement and Materials Management
Skills:
Lean Six Sigma, Business Process, Sales and Operations Planning, Production Activity Control, Distribution Center Operations, Logistics, Supply Chain, Business Transformation, Customer Service, SAP Warehouse Management, Warehouse Management, SAP Logistics, SAP Sales & Distribution, SAP Logistics Execution, Inventory Management, Project Management, EDI, SAP CRM, Demand Supply Planning, Master Scheduling, Production Operations Management, Procurement, Materials Management, SAP, Supply Chain Management, ERP, SAP R/3, Data Migration
Certifications:
Certified Supply Chain Professional (CSCP), American Production and Inventory Control Society (APICS)
Certified in Production and Inventory Management (CPIM), American Production and Inventory Control Society (APICS)
Certified in Production and Inventory Management (CPIM), American Production and Inventory Control Society (APICS)
Deacetylase Inhibitor Therapy
Deacetylase Inhibitor Therapy
US Patent:
2008012, May 29, 2008
Filed:
Jun 7, 2007
Appl. No.:
11/759471
Inventors:
William McCulloch - Raleigh NC, US
Richard L. Piekarz - Silver Spring MD, US
Susan E. Bates - Bethesda MD, US
Richard L. Piekarz - Silver Spring MD, US
Susan E. Bates - Bethesda MD, US
International Classification:
A61K 33/06, A61K 33/24, A61P 25/00, A61P 35/00, A61P 35/02, A61P 37/00
US Classification:
424682, 424617
Abstract:
The present invention relates to deacetylase inhibitor (e.g., histone deacetylase inhibitor) therapies and demonstrates that individuals with low electrolyte levels may have increased susceptibility to certain unwanted side effects such as cardiac side effects. In some embodiments, the invention provides methods of administering DAC or DAC inhibitor therapy that includes electrolyte supplementation.
Gemcitabine Combination Therapy
Gemcitabine Combination Therapy
US Patent:
2010013, Jun 3, 2010
Filed:
Apr 13, 2007
Appl. No.:
12/298265
Inventors:
William McCulloch - Raleigh NC, US
Mitchell Keegan - Marlborough MA, US
Mitchell Keegan - Marlborough MA, US
Assignee:
GLOUCESTER PHARMACEUTICALS - Cambridge MA
International Classification:
A61K 31/7068, A61P 35/00
US Classification:
514 49
Abstract:
The present invention provides compositions and methods for the treatment of cell proliferative disorders using at least one DAC inhibitor and gemcitabine.
Treatment Of Ras-Expressing Tumors
Treatment Of Ras-Expressing Tumors
US Patent:
2009030, Dec 10, 2009
Filed:
Apr 13, 2007
Appl. No.:
12/298436
Inventors:
William McCulloch - Raleigh NC, US
Mitchell Keegan - Marlborough MA, US
Mitchell Keegan - Marlborough MA, US
International Classification:
A61K 38/15, A61P 35/00
US Classification:
514 9
Abstract:
The present invention provides compositions and methods for the treatment of /?αs-expressing tumors using at least one DAC inhibitor (e.g., romidepsin).
Gemcitabine Combination Therapy
Gemcitabine Combination Therapy
US Patent:
2014000, Jan 2, 2014
Filed:
Mar 26, 2013
Appl. No.:
13/851053
Inventors:
William MCCULLOCH - Raleigh NC, US
Mitchell KEEGAN - Marlborough MA, US
Mitchell KEEGAN - Marlborough MA, US
Assignee:
CELGENE CORPORATION - Summit NJ
International Classification:
A61K 38/12, A61K 45/06, A61K 31/7068
US Classification:
514 199, 514 49
Abstract:
The present invention provides compositions and methods for the treatment of cell proliferative disorders using at least one DAC inhibitor and gemcitabine.
Gemcitabine Combination Therapy
Gemcitabine Combination Therapy
US Patent:
2012030, Nov 29, 2012
Filed:
May 29, 2012
Appl. No.:
13/482940
Inventors:
William McCulloch - Raleigh NC, US
Mitchell Keegan - Berlin MA, US
Mitchell Keegan - Berlin MA, US
International Classification:
A61K 31/7068, A61P 35/00
US Classification:
514 49
Abstract:
The present invention provides compositions and methods for the treatment of cell proliferative disorders using at least one DAC inhibitor and gemcitabine.
Accelerated Therapy
Accelerated Therapy
US Patent:
2010015, Jun 17, 2010
Filed:
Jul 30, 2009
Appl. No.:
12/512419
Inventors:
William McCulloch - Raleigh NC, US
Henry Miles Prince - Elsternwick, AU
Henry Miles Prince - Elsternwick, AU
International Classification:
A61K 38/15, A61P 1/00, A61P 9/00
US Classification:
514 10
Abstract:
The present invention encompasses the surprising finding that romidepsin can safely be administered to humans on an accelerated dosing schedule.